Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a rare autosomal recessive disorder of infancy and childhood that is invariably fatal if not treated. We report on the first patient to receive post-natal HSCT for HLH after receiving in utero chemotherapy for disease stabilization.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Cognition Disorders
-
Developmental Disabilities
-
Female
-
Fetal Therapies
-
Fetus
-
Follow-Up Studies
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Infant, Newborn
-
Lymphohistiocytosis, Hemophagocytic / diagnosis*
-
Lymphohistiocytosis, Hemophagocytic / physiopathology
-
Lymphohistiocytosis, Hemophagocytic / therapy*
-
Pregnancy